BENEDETTI, MARIADONATA
 Distribuzione geografica
Continente #
NA - Nord America 4.159
EU - Europa 2.981
AS - Asia 2.281
SA - Sud America 300
AF - Africa 29
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 9.768
Nazione #
US - Stati Uniti d'America 4.126
CN - Cina 1.030
GB - Regno Unito 940
SG - Singapore 808
SE - Svezia 375
IT - Italia 346
BR - Brasile 259
FR - Francia 257
RU - Federazione Russa 252
HK - Hong Kong 242
FI - Finlandia 223
IE - Irlanda 208
DE - Germania 204
UA - Ucraina 60
VN - Vietnam 38
KR - Corea 32
BE - Belgio 29
TR - Turchia 28
CA - Canada 17
IN - India 17
JP - Giappone 16
NL - Olanda 13
IR - Iran 12
AR - Argentina 11
AT - Austria 10
CZ - Repubblica Ceca 10
PL - Polonia 10
EC - Ecuador 9
MX - Messico 9
AU - Australia 8
ID - Indonesia 8
IL - Israele 7
BD - Bangladesh 6
CH - Svizzera 6
DK - Danimarca 6
ES - Italia 6
EU - Europa 6
GR - Grecia 6
IQ - Iraq 6
MA - Marocco 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CL - Cile 5
CO - Colombia 5
PY - Paraguay 5
SA - Arabia Saudita 5
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JO - Giordania 3
KG - Kirghizistan 3
RO - Romania 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
DZ - Algeria 2
KE - Kenya 2
KH - Cambogia 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
SN - Senegal 2
TG - Togo 2
VE - Venezuela 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.768
Città #
Southend 814
Chandler 611
Jacksonville 428
Singapore 414
Woodbridge 410
Dallas 369
Ann Arbor 301
Ashburn 298
Hong Kong 239
Dublin 208
Houston 180
Beijing 137
New York 106
Verona 102
Wilmington 97
Lawrence 89
Princeton 89
Nanjing 85
Jinan 79
Hebei 74
Helsinki 73
Shenyang 62
Munich 41
Haikou 40
The Dalles 40
Tianjin 39
Changsha 38
Boardman 37
Ningbo 37
Columbus 33
Los Angeles 33
Zhengzhou 31
Brussels 29
Buffalo 28
Taiyuan 28
Hangzhou 27
Lancaster 27
Milan 27
Washington 27
Nanchang 26
Taizhou 25
Council Bluffs 24
Fuzhou 24
Sindelfingen 22
São Paulo 22
Turku 21
Redmond 20
Redwood City 20
Santa Clara 19
Guangzhou 18
Istanbul 18
Jiaxing 18
Bologna 17
Norwalk 16
Auburn Hills 15
Seattle 15
Falls Church 14
Lanzhou 14
Brooklyn 13
Düsseldorf 12
Moscow 12
Tokyo 12
Belo Horizonte 11
Clearwater 11
Dong Ket 10
Olomouc 10
Riva 10
San Francisco 10
Kemerovo 9
Redondo Beach 9
Boston 8
Nuremberg 8
Rome 8
Seoul 8
Bolzano 7
Chicago 7
Frankfurt am Main 7
Rio de Janeiro 7
Stockholm 7
Amsterdam 6
Arco 6
Ardabil 6
Atlanta 6
Fairfield 6
Ho Chi Minh City 6
Kent 6
San Mateo 6
Warsaw 6
Brasília 5
Charlotte 5
Cleveland 5
Dearborn 5
Hanoi 5
Jakarta 5
London 5
Paris 5
Tashkent 5
Tehran 5
Vienna 5
Wuhan 5
Totale 6.505
Nome #
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 195
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 174
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 161
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 158
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 156
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 156
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 149
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 148
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 144
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 143
Cognitive onset in multiple sclerosis 139
A case of acute fulminant multiple sclerosis treated with alemtuzumab 135
COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk 131
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 129
Apporto della neurofisiologia allo studio delle disfunzioni dell'apparato uro-genitale 128
Effects of pulsed electromagnetic fields on nerve regeneration: an experimental study in the rat 127
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 126
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 124
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 124
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 123
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 123
Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases 122
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 122
Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro 121
Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immuno-cytochemical and morphometric study 121
Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. 121
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 120
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 120
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 119
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 118
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? 117
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 117
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 116
Multifactorial etiological aspects of epilepsy 115
Epilessia ed imaging 115
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 115
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study 115
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 115
Epilepsy in multiple sclerosis: The role of temporal lobe damage 115
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 114
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 114
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial 114
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 114
Short term prognosis of stroke in a clinical series of 94 patients 112
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 112
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 112
Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. 111
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 109
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 109
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 108
Resting motor threshold in idiopathic generalized epilepsies: A systematic review with meta-analysis. 106
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 104
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 104
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 104
Prognosi del Piccolo Male-assenze tipiche. Studio di follow-up su 60 casi. [Prognosis of pure petit mal. Follow-up study of 60 cases] 102
Prevalence of dementia and apoliprotein E genotype distribution in the elderly of Buttapietra, Verona Province, Italy 102
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 101
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 101
Long survival and clinical stability in Marburg's variant multiple sclerosis. 100
Prognosis of Epilepsy in Newly Referred Patients: A Multicenter Prospective Study of the Effects of Monotherapy on the Long‐Term Course of Epilepsy 96
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. 95
Prognostic factors of acute partial transverse myelitis. 94
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 94
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 93
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 93
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis 92
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 92
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 91
A multicentric prospective incidence study of Guillain-Barré Syndrome in Italy. The ITANG Study 91
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study 91
Azathioprine in multiple sclerosis 90
Efficacia della monoterapia in pazienti epilettici di nuova diagnosi e precedentemente non trattati. Studio prospettico 89
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study 87
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 87
Use of plasma levels for antiepileptic drug monitoring in clinical practice 86
Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. 85
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 85
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 83
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 83
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. 77
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 76
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 74
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial 72
Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease 67
Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis 65
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluid. 63
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. 63
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. 63
Trial of minocycline in clinically isolated syndrome of Multiple Sclerosis 63
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 61
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080) 55
Totale 9.866
Categoria #
all - tutte 35.900
article - articoli 34.674
book - libri 0
conference - conferenze 404
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 822
Totale 71.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021598 0 0 49 92 97 92 17 41 39 35 92 44
2021/2022938 85 350 12 122 19 23 10 54 26 18 51 168
2022/20231.607 109 195 140 290 126 364 12 114 176 11 49 21
2023/2024860 30 72 83 85 101 195 26 78 6 33 90 61
2024/20251.832 95 128 104 288 111 71 93 72 252 97 152 369
2025/20261.019 408 266 345 0 0 0 0 0 0 0 0 0
Totale 9.866